We are a multi-award-winning performance marketing company and a leading provider of digital marketing services active exclusively in the online gambling industry, based on Dec. 31, 2020, and March 31, 2021, revenue. Our principal focus is on iGaming and sports betting. Through our proprietary technology platform, we publish a portfolio of premier branded websites including Gambling.com […]

DISCO provides a cloud-native, artificial intelligence-powered legal solution that simplifies ediscovery, legal document review and case management for enterprises, law firms, legal services providers and governments. Our scalable, integrated solution enables legal departments to easily collect, process and review enterprise data that is relevant or potentially relevant to legal matters. We leverage a cloud-native architecture […]

Zevia – its name rhymes with stevia, the natural sweetener and sugar substitute – is a high-growth beverage company that is disrupting the liquid refreshment beverage industry through delicious and refreshing zero calorie, zero sugar, naturally sweetened beverages that are all Non-GMO Project Verified. (The Stevia rebaudiana plant is native to Brazil and Paraguay.) We […]

(Note: This is a SPAC or blank-check IPO of Class A ordinary shares – and NOT units. Most SPAC or blank-check IPOs consist of units.) As the name indicates, this is the fifth SPAC established and led by the founder and key executives of Perceptive Advisors, an investment firm focused on the healthcare industry, especially […]

We are a preclinical-stage biopharmaceutical company focused on developing a robust pipeline of T cell receptor-engineered T cell, or TCR-T, therapies to treat patients with cancer. Our approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not. Using one […]

We are a leading commercial-stage precision health company focused on democratizing high-quality care globally through the use of our proprietary digital technologies that enable healthcare providers to provide better care for patients.  Our product portfolio comprises cloud-based AI-driven software that uses medical images to provide better decision support for the diagnosis, stratification and monitoring of patients with chronic […]

We are a clinical-stage biopharmaceutical company discovering and developing small molecule product candidates that target lysine-specific demethylase 1, or LSD1, an enzyme that plays a central role in the production of blood cells in the bone marrow. We are focused on improving the quality of life of patients with cancer and bone marrow diseases in […]

  At Erasca, our name is our mission: to erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Molecular alterations in RAS, the most frequently mutated oncogene, and the MAPK pathway, one of the most frequently altered signaling pathways in cancer, account for […]

We are an innovative life sciences technology company providing automated microbial quality control (MQC) to facilitate the efficient manufacturing as well as the fast and safe release of healthcare products such as biologics, vaccines, cell and gene therapies and sterile injectables. Our flagship Growth Direct platform automates and modernizes the antiquated manual microbial quality control […]

We are a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. We are initially focused on developing treatments for neuromuscular diseases, beginning with myotubular and centronuclear myopathies, or CNM, a group of devastating rare genetic disorders characterized by […]